U. Ilgen Et Al. , "Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations," RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, pp.593-598, 2017
Ilgen, U. Et Al. 2017. Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations. RHEUMATOLOGY INTERNATIONAL , vol.37, no.4 , 593-598.
Ilgen, U., Yayla, M. E., & Duzgun, N., (2017). Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations. RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, 593-598.
Ilgen, Ufuk, MÜÇTEBA ENES YAYLA, And Nursen Duzgun. "Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations," RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, 593-598, 2017
Ilgen, Ufuk Et Al. "Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations." RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, pp.593-598, 2017
Ilgen, U. Yayla, M. E. And Duzgun, N. (2017) . "Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations." RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, pp.593-598.
@article{article, author={Ufuk Ilgen Et Al. }, title={Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2017, pages={593-598} }